For full functionality of this site it is necessary to enable JavaScript. Here are the
instructions how to enable JavaScript in your web browser
.
jump to content
jump to footer
Institute of Cell Biology and Immunology
Uni
versity of Stuttgart
F
aculty
04
Language of this page
de
en
Search
Main navigation
Search
Suche
back
Institute
Research
Teaching
Open positions
Institute
Recent
Team
Publications
Contact us
Research
Prof. Dr. Markus Morrison (Rehm) - Cell Biology and Immunology
Prof. Monilola Olayioye - Molecular Tumor Biology
Prof. Roland Kontermann - Biomedical Engineering
Dr. Angelika Hausser - Membrane Trafficking and Signalling
Dr. Dafne Müller - Immuno-Oncology
Dr. Andrew Clark - Cell Biology of the Intestine
Jun-Prof. Dr. Chengzhe Tian - Signaling Dynamics of Cellular Biomedical Systems
close navigation
Position within the page tree
Move path to the left
Move path to the right
Home
Institute
Recent
OMTX705, a first-in-class tumor microenvironment-targeted ADC developed by Oncomatryx in collaboration with IZI and other institutions received FDA and AEMPS IND clearance to treat advanced solid tumors
OMTX705, a first-in-class tumor microenvironment-targeted ADC developed by Oncomatryx in collaboration with IZI and other institutions received FDA and AEMPS IND clearance to treat advanced solid tumors
June 7, 2022
Read the news on finanznachrichten.de
To the top of the page
